Novo Nordisk UK has announced that insulin degludec (brand name Tresiba(R)), a new oncedaily basal insulin for adult patients with type 1 and type 2 diabetes, is available in the UK as a new treatment option.
Read more
A New Basal Insulin For TI and TII Diabetes Is Available In The UK
Posted in Glucose & Insulin